Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.

Post-translational hydroxylation has been considered an unusual modification on intracellular proteins. However, following the recognition that oxygen-sensitive prolyl and asparaginyl hydroxylation are central to the regulation of the transcription factor hypoxia-inducible factor (HIF), interest has...

Full description

Bibliographic Details
Main Authors: Cockman, M, Webb, J, Kramer, H, Kessler, B, Ratcliffe, P
Format: Journal article
Language:English
Published: 2009
_version_ 1797082807472750592
author Cockman, M
Webb, J
Kramer, H
Kessler, B
Ratcliffe, P
author_facet Cockman, M
Webb, J
Kramer, H
Kessler, B
Ratcliffe, P
author_sort Cockman, M
collection OXFORD
description Post-translational hydroxylation has been considered an unusual modification on intracellular proteins. However, following the recognition that oxygen-sensitive prolyl and asparaginyl hydroxylation are central to the regulation of the transcription factor hypoxia-inducible factor (HIF), interest has centered on the possibility that these enzymes may have other substrates in the proteome. In support of this certain ankyrin repeat domain (ARD)-containing proteins, including members of the IkappaB and Notch families, have been identified as alternative substrates of the HIF asparaginyl hydroxylase factor inhibiting HIF (FIH). Although these findings imply a potentially broad range of substrates for FIH, the precise extent of this range has been difficult to determine because of the difficulty of capturing transient enzyme-substrate interactions. Here we describe the use of pharmacological "substrate trapping" together with stable isotope labeling by amino acids in cell culture (SILAC) technology to stabilize and identify potential FIH-substrate interactions by mass spectrometry. To pursue these potential FIH substrates we used conventional data-directed tandem MS together with alternating low/high collision energy tandem MS to assign and quantitate hydroxylation at target asparaginyl residues. Overall the work has defined 13 new FIH-dependent hydroxylation sites with a degenerate consensus corresponding to that of the ankyrin repeat and a range of ARD-containing proteins as actual and potential substrates for FIH. Several ARD-containing proteins were multiply hydroxylated, and detailed studies of one, Tankyrase-2, revealed eight sites that were differentially sensitive to FIH-catalyzed hydroxylation. These findings indicate that asparaginyl hydroxylation is likely to be widespread among the approximately 300 ARD-containing species in the human proteome.
first_indexed 2024-03-07T01:33:04Z
format Journal article
id oxford-uuid:943e56b5-cdf0-4299-ab9c-2c2d3730c5b6
institution University of Oxford
language English
last_indexed 2024-03-07T01:33:04Z
publishDate 2009
record_format dspace
spelling oxford-uuid:943e56b5-cdf0-4299-ab9c-2c2d3730c5b62022-03-26T23:38:00ZProteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:943e56b5-cdf0-4299-ab9c-2c2d3730c5b6EnglishSymplectic Elements at Oxford2009Cockman, MWebb, JKramer, HKessler, BRatcliffe, PPost-translational hydroxylation has been considered an unusual modification on intracellular proteins. However, following the recognition that oxygen-sensitive prolyl and asparaginyl hydroxylation are central to the regulation of the transcription factor hypoxia-inducible factor (HIF), interest has centered on the possibility that these enzymes may have other substrates in the proteome. In support of this certain ankyrin repeat domain (ARD)-containing proteins, including members of the IkappaB and Notch families, have been identified as alternative substrates of the HIF asparaginyl hydroxylase factor inhibiting HIF (FIH). Although these findings imply a potentially broad range of substrates for FIH, the precise extent of this range has been difficult to determine because of the difficulty of capturing transient enzyme-substrate interactions. Here we describe the use of pharmacological "substrate trapping" together with stable isotope labeling by amino acids in cell culture (SILAC) technology to stabilize and identify potential FIH-substrate interactions by mass spectrometry. To pursue these potential FIH substrates we used conventional data-directed tandem MS together with alternating low/high collision energy tandem MS to assign and quantitate hydroxylation at target asparaginyl residues. Overall the work has defined 13 new FIH-dependent hydroxylation sites with a degenerate consensus corresponding to that of the ankyrin repeat and a range of ARD-containing proteins as actual and potential substrates for FIH. Several ARD-containing proteins were multiply hydroxylated, and detailed studies of one, Tankyrase-2, revealed eight sites that were differentially sensitive to FIH-catalyzed hydroxylation. These findings indicate that asparaginyl hydroxylation is likely to be widespread among the approximately 300 ARD-containing species in the human proteome.
spellingShingle Cockman, M
Webb, J
Kramer, H
Kessler, B
Ratcliffe, P
Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
title Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
title_full Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
title_fullStr Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
title_full_unstemmed Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
title_short Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins.
title_sort proteomics based identification of novel factor inhibiting hypoxia inducible factor fih substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain containing proteins
work_keys_str_mv AT cockmanm proteomicsbasedidentificationofnovelfactorinhibitinghypoxiainduciblefactorfihsubstratesindicateswidespreadasparaginylhydroxylationofankyrinrepeatdomaincontainingproteins
AT webbj proteomicsbasedidentificationofnovelfactorinhibitinghypoxiainduciblefactorfihsubstratesindicateswidespreadasparaginylhydroxylationofankyrinrepeatdomaincontainingproteins
AT kramerh proteomicsbasedidentificationofnovelfactorinhibitinghypoxiainduciblefactorfihsubstratesindicateswidespreadasparaginylhydroxylationofankyrinrepeatdomaincontainingproteins
AT kesslerb proteomicsbasedidentificationofnovelfactorinhibitinghypoxiainduciblefactorfihsubstratesindicateswidespreadasparaginylhydroxylationofankyrinrepeatdomaincontainingproteins
AT ratcliffep proteomicsbasedidentificationofnovelfactorinhibitinghypoxiainduciblefactorfihsubstratesindicateswidespreadasparaginylhydroxylationofankyrinrepeatdomaincontainingproteins